查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808876

癌症成像系統市場，按成像方式、按應用、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Cancer Imaging System Market, By Imaging Modality, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年癌症影像系統市場規模價值 219.8724 億美元，2025 年至 2032 年的複合年成長率為 9.5%。

癌症影像系統市場是指專注於透過醫學影像檢測、診斷和監測癌症的技術和設備的全球產業。這些系統包括MRI（磁振造影）、CT（電腦斷層掃描）、PET（正子斷層掃描）、超音波和乳房X光檢查等。癌症影像在早期發現、分期、治療計劃和療效評估中發揮著至關重要的作用。全球癌症盛行率的上升、人們對早期診斷認知的提高以及成像技術的進步是該市場發展的關鍵促進因素。

人工智慧增強影像解讀、混合成像系統和分子成像等創新技術正在提高診斷準確性和能力。世界各地的政府和衛生組織正在投資癌症篩檢項目，進一步刺激了需求。此外，日益成長的老齡化人口和與生活方式相關的癌症風險也促進了市場擴張。然而，高昂的設備成本和低收入地區的醫療資源匱乏仍然是個挑戰。總體而言，市場正在快速發展，以支持精準腫瘤學和以患者為中心的醫療服務。

癌症影像系統市場-市場動態

放射組學透過提取數據驅動的腫瘤見解來實現個人化癌症成像。

癌症影像系統市場的一個利基促進因素是放射組學在個人化腫瘤治療中的應用日益廣泛。放射組學利用先進的演算法從醫學影像中提取大量定量資料。這些資料點可以揭示肉眼無法觀察到的腫瘤特徵，例如形狀、紋理和強度。這些資訊有助於評估腫瘤異質性、預測治療反應並提高預後準確性。隨著精準醫療的進展，放射組學對於根據患者個別情況制定個人化癌症治療方案至關重要。

它提供了一種非侵入性的方式來收集腫瘤生物學資訊，從而減少了重複活體組織切片的需要。與人工智慧的結合增強了其檢測模式和相關性的能力。放射組學也支持臨床決策，並加速癌症治療的研究。其在CT、MRI和PET等影像模式下的應用正在不斷擴展。人們對數據驅動型醫療保健的日益關注進一步增強了其作用。隨著應用的不斷成長，放射組學必將對癌症成像策略產生重大影響。

癌症影像系統市場-關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 9.5%。

根據成像模式細分，預計磁振造影 (MRI) 將在 2024 年佔據最大市場佔有率

根據應用細分，乳癌是 2024 年的主要應用

從地區來看，北美是 2024 年最大的收入來源

癌症影像系統市場-細分分析：

全球癌症成像系統市場根據成像方式、應用、最終用戶和地區進行細分。

根據影像方式，市場分為三類：磁振造影 (MRI)、電腦斷層掃描 (CT)、正子斷層掃描 (PET)、超音波、乳房 X 光攝影和其他。磁振造影 (MRI) 是癌症成像系統市場中最主要的細分領域，因為它具有卓越的軟組織對比度，並且能夠在沒有電離輻射的情況下提供清晰的圖像。 MRI 廣泛用於檢測和分期各種癌症，包括腦癌、乳癌、攝護腺癌和肝癌。

其先進的功能性成像技術，例如擴散加權成像和光譜技術，能夠更好地表徵腫瘤並監測治療效果。隨著對非侵入式精準診斷工具的需求不斷成長，以及技術的持續進步，進一步鞏固了MRI在該市場的領先地位。

根據應用，市場分為兩類：乳癌、肺癌、大腸癌、攝護腺癌、肝癌和其他。乳癌是癌症影像系統市場中最主要的細分領域，因為其發生率高，且對早期檢測和篩檢的需求迫切。乳房X光檢查和核磁振造影（MRI）廣泛應用於乳癌影像，以實現精準的診斷和監測。

政府篩檢計畫和日益成長的乳癌意識推動了影像系統的需求成長。此外，影像技術的進步提高了對小腫瘤的檢測能力，從而改善了治療效果。對乳癌的強烈關注推動了該領域市場的顯著成長。

癌症成像系統市場-地理洞察

北美在癌症成像系統市場佔據主導地位，這得益於其高癌症盛行率、先進的醫療基礎設施以及對醫療技術的強勁投入。美國憑藉其廣泛採用的先進成像模式以及人工智慧在診斷中的應用，引領了該地區的發展。政府的支持性舉措以及對早期檢測日益成長的需求進一步推動了市場的成長。加拿大也為癌症篩檢計畫的興起和現代影像設備普及率的提高做出了貢獻。

美國是全球最大的癌症影像系統市場，得益於其高發病率和完善的醫療保健體系。該國在診斷技術方面投入了大量資金，MRI、CT、PET 和混合成像技術廣泛應用於早期癌症檢測和治療監測。諸如「癌症登月計畫」和擴大醫療保險對篩檢程序覆蓋範圍等政府舉措，提升了影像服務的可及性。

癌症影像系統市場-競爭格局：

癌症影像系統市場的競爭格局以多家全球和地區性企業為特徵，這些企業提供廣泛的影像解決方案。通用電氣醫療、西門子醫療和飛利浦醫療等產業領導者憑藉全面的影像產品組合和強大的研發實力佔據主導地位。這些公司專注於創新，整合人工智慧、放射組學和先進軟體，以提高診斷精度。佳能醫療和富士膠片等中型企業則透過利基技術和策略合作夥伴關係競爭。新創公司和新興公司正透過提供針對腫瘤學的人工智慧驅動成像解決方案而不斷取得進展。

市場競爭激烈，參與者紛紛投資FDA核准、與癌症研究機構合作、全球擴張。技術進步，尤其是在混合成像和分子診斷領域的進步，正在重塑市場格局。定價策略、服務產品和安裝後支援也會影響競爭定位。個人化醫療和早期癌症檢測的推動力持續推動關鍵利害關係人之間的創新和競爭。

最新動態：

2024年12月，Guardant Health, Inc. 宣布與勃林格殷格翰建立合作夥伴關係，以獲得監管部門的批准並推進Guardant360 CDx液體活體組織切片的商業化。此次合作的重點是將液體活體組織切片技術作為zongertinib的伴隨診斷（CDx）。 zongertinib是一種新型共價酪胺酸激酶抑制劑（TKI），可選擇性靶向HER2，同時最大程度地降低對非小細胞肺癌（NSCLC）中表皮生長因子受體（EGFR）的影響。

丹納赫集團於2024年11月宣布，計畫成立兩個新的診斷創新中心，以推動精準醫療的發展。第一個中心位於英國紐卡斯爾，預計將於7月投入營運，並將成為丹納赫與領先製藥和學術合作夥伴的合作研究中心。該中心由丹納赫旗下子公司徠卡生物系統公司經營，將成為丹納赫首個獲得CLIA CAP認證的實驗室。

目錄

第1章：癌症影像系統市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 癌症影像系統市場片段（以影像方式）
    • 癌症影像系統市場片段（按應用）
    • 癌症影像系統市場片段（按最終用戶）
    • 癌症影像系統市場（按國家/地區）
    • 癌症影像系統市場（按地區）
  • 競爭洞察

第3章：癌症影像系統關鍵市場趨勢

  • 癌症影像系統市場促進因素
    • 市場促進因素的影響分析
  • 癌症影像系統市場限制因素
    • 市場限制的影響分析
  • 癌症影像系統市場機遇
  • 癌症影像系統市場未來趨勢

第4章：癌症影像系統產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：癌症影像系統市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：癌症影像系統市場格局

  • 2024年癌症影像系統市佔分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：癌症影像系統市場－依影像方式

  • 概述
    • 按成像方式分類的細分市場佔有率分析
    • 磁振造影（MRI）
    • 電腦斷層掃描（CT）
    • 正子斷層掃描（PET）
    • 超音波
    • 乳房X光檢查
    • 其他

第 8 章：癌症影像系統市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 乳癌
    • 肺癌
    • 大腸直腸癌
    • 攝護腺癌
    • 肝癌
    • 其他

第9章：癌症影像系統市場－按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 診斷影像中心
    • 專科診所
    • 學術和研究機構

第 10 章：癌症影像系統市場-按地域分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美癌症成像系統主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（依影像方式）
    • 北美市場規模和預測（按應用）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲癌症成像系統主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（依影像方式）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區癌症影像系統主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依影像方式）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲癌症成像系統主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（以成像方式）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲癌症影像系統主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依影像方式）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：關鍵供應商分析-癌症影像系統產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • GE HealthCare
    • Siemens Healthineers
    • Philips Healthcare
    • Canon Medical Systems
    • Fujifilm Holdings
    • Hologic Inc.
    • Bracco Imaging
    • Carestream Health
    • Esaote SpA
    • Shimadzu Corporation
    • Samsung Medison
    • United Imaging Healthcare
    • PerkinElmer Inc.
    • Agfa-Gevaert Group
    • Konica Minolta Healthcare
    • Mindray Medical International
    • Neusoft Medical Systems
    • ViewRay Inc.
    • Hyperfine Inc.
    • Median Technologies

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5509

Cancer Imaging System Market size was valued at US$ 21,987.24 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Cancer Imaging System market refers to the global industry focused on technologies and equipment used to detect, diagnose, and monitor cancer through medical imaging. These systems include modalities such as MRI (Magnetic Resonance Imaging), CT (Computed Tomography), PET (Positron Emission Tomography), ultrasound, and mammography. Cancer imaging plays a vital role in early detection, staging, treatment planning, and evaluating the effectiveness of therapies. Increasing global cancer prevalence, rising awareness about early diagnosis, and advancements in imaging technologies are key drivers of this market.

Innovations like AI-enhanced image interpretation, hybrid imaging systems, and molecular imaging are improving accuracy and diagnostic capabilities. Governments and health organizations worldwide are investing in cancer screening programs, further fueling demand. Moreover, the growing aging population and lifestyle-related cancer risks contribute to market expansion. However, high equipment costs and limited access in low-income regions remain challenges. Overall, the market is evolving rapidly to support precision oncology and patient-centred care.

Cancer Imaging System Market- Market Dynamics

Radiomics enables personalized cancer imaging by extracting data-driven tumor insights.

A niche driver in the Cancer Imaging System market is the growing use of radiomics for personalized oncology. Radiomics involves extracting large volumes of quantitative data from medical images using advanced algorithms. These data points can reveal tumor characteristics such as shape, texture, and intensity that are not visible to the naked eye. This information helps in assessing tumor heterogeneity, predicting treatment response, and improving prognostic accuracy. As precision medicine advances, radiomics is becoming crucial for tailoring cancer treatment to individual patients.

It offers a non-invasive way to gather tumor biology insights, reducing the need for repeated biopsies. Integration with artificial intelligence enhances its ability to detect patterns and correlations. Radiomics also supports clinical decision-making and speeds up research in cancer therapeutics. Its application is expanding in imaging modalities like CT, MRI, and PET. The increasing focus on data-driven healthcare further strengthens its role. As adoption grows, radiomics is set to significantly impact cancer imaging strategies.

Cancer Imaging System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2025-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging (MRI) was predicted to show maximum market share in the year 2024

Based on application segmentation, Breast Cancer was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Cancer Imaging System Market- Segmentation Analysis:

The Global Cancer Imaging System Market is segmented on the basis of Imaging Modality, Application, End-user, and Region.

The market is divided into three categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, Mammography, and Others. Magnetic Resonance Imaging (MRI) is the most dominant segment in the Cancer Imaging System market due to its superior soft tissue contrast and ability to provide detailed images without ionizing radiation. MRI is widely used for detecting and staging various cancers, including brain, breast, prostate, and liver cancers.

Its advanced functional imaging techniques, such as diffusion-weighted imaging and spectroscopy, enable better tumor characterization and treatment monitoring. Growing demand for non-invasive and precise diagnostic tools, along with continuous technological advancements, further strengthens MRI's leading position in this market.

The market is divided into two categories based on application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Others. Breast Cancer is the most dominant segment in the Cancer Imaging System market due to its high prevalence and the critical need for early detection and screening. Mammography and MRI are widely used for breast cancer imaging, enabling accurate diagnosis and monitoring.

Government screening programs and growing awareness about breast cancer contribute to increased demand for imaging systems. Additionally, advancements in imaging technology have improved the detection of small tumors, enhancing treatment outcomes. This strong focus on breast cancer drives significant market growth within this segment.

Cancer Imaging System Market- Geographical Insights

North America holds a dominant position in the Cancer Imaging System market, driven by high cancer prevalence, advanced healthcare infrastructure, and strong investment in medical technology. The U.S. leads the region with widespread adoption of advanced imaging modalities and integration of AI in diagnostics. Supportive government initiatives and increasing demand for early detection further boost growth. Canada also contributes to rising cancer screening programs and growing access to modern imaging equipment.

The United States represents the largest market for cancer imaging systems globally, supported by a high incidence of cancer and a well-established healthcare system. The country sees significant investments in diagnostic technologies, with widespread use of MRI, CT, PET, and hybrid imaging for early cancer detection and treatment monitoring. Government initiatives like the Cancer Moonshot and expanded Medicare coverage for screening procedures enhance accessibility to imaging services.

Cancer Imaging System Market- Competitive Landscape:

The competitive landscape of the Cancer Imaging System market is characterized by the presence of several global and regional players offering a wide range of imaging solutions. Industry leaders like GE HealthCare, Siemens Healthineers, and Philips Healthcare dominate with comprehensive imaging portfolios and strong R&D capabilities. These companies focus on innovation, integrating AI, radiomics, and advanced software to improve diagnostic precision. Mid-tier players such as Canon Medical and Fujifilm compete through niche technologies and strategic partnerships. Startups and emerging firms are gaining ground by offering AI-driven imaging solutions tailored for oncology.

The market is highly competitive, with players investing in FDA approvals, collaborations with cancer research institutions, and global expansion. Technological advancements, especially in hybrid imaging and molecular diagnostics, are reshaping market dynamics. Pricing strategies, service offerings, and post-installation support also influence competitive positioning. The push toward personalized medicine and early cancer detection continues to drive innovation and rivalry among key stakeholders.

Recent Developments:

In December 2024, Guardant Health, Inc. announced a partnership with Boehringer Ingelheim to secure regulatory approval and advance the commercialization of the Guardant360 CDx liquid biopsy. This collaboration focuses on utilizing the liquid biopsy as a companion diagnostic (CDx) for zongertinib, a novel covalent tyrosine kinase inhibitor (TKI) that selectively targets HER2 while minimizing effects on the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC).

In November 2024, Danaher Corporation revealed plans to establish two new Centers of Innovation in Diagnostics to drive advancements in precision medicine. The first center, based in Newcastle, UK, is set to open in July and will serve as a collaborative research hub with leading pharmaceutical and academic partners. Operated by Leica Biosystems, a Danaher subsidiary, this facility will become Danaher's first CLIA CAP-certified laboratory.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMAGING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE HealthCare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Holdings
  • Hologic Inc.
  • Bracco Imaging
  • Carestream Health
  • Esaote SpA
  • Shimadzu Corporation
  • Samsung Medison
  • United Imaging Healthcare
  • PerkinElmer Inc.
  • Agfa-Gevaert Group
  • Konica Minolta Healthcare
  • Mindray Medical International
  • Neusoft Medical Systems
  • ViewRay Inc.
  • Hyperfine Inc.
  • Median Technologies

GLOBAL CANCER IMAGING SYSTEM MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Ultrasound
  • Mammography
  • Others

GLOBAL CANCER IMAGING SYSTEM MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Others

GLOBAL CANCER IMAGING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Clinics
  • Academic and Research Institutes

GLOBAL CANCER IMAGING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Imaging System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Imaging System Market Snippet by Imaging Modality
    • 2.1.2. Cancer Imaging System Market Snippet by Application
    • 2.1.3. Cancer Imaging System Market Snippet by End-user
    • 2.1.4. Cancer Imaging System Market Snippet by Country
    • 2.1.5. Cancer Imaging System Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Imaging System Key Market Trends

  • 3.1. Cancer Imaging System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Imaging System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Imaging System Market Opportunities
  • 3.4. Cancer Imaging System Market Future Trends

4. Cancer Imaging System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Imaging System Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cancer Imaging System Market Landscape

  • 6.1. Cancer Imaging System Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Imaging System Market - By Imaging Modality

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Imaging Modality, 2024 & 2032 (%)
    • 7.1.2. Magnetic Resonance Imaging (MRI)
    • 7.1.3. Computed Tomography (CT)
    • 7.1.4. Positron Emission Tomography (PET)
    • 7.1.5. Ultrasound
    • 7.1.6. Mammography
    • 7.1.7. Others

8. Cancer Imaging System Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Breast Cancer
    • 8.1.3. Lung Cancer
    • 8.1.4. Colorectal Cancer
    • 8.1.5. Prostate Cancer
    • 8.1.6. Liver Cancer
    • 8.1.7. Others

9. Cancer Imaging System Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Imaging Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Academic and Research Institutes

10. Cancer Imaging System Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Imaging System Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Imaging System Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Imaging System Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cancer Imaging System Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cancer Imaging System Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Imaging System Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. GE HealthCare
    • 11.2.2. Siemens Healthineers
    • 11.2.3. Philips Healthcare
    • 11.2.4. Canon Medical Systems
    • 11.2.5. Fujifilm Holdings
    • 11.2.6. Hologic Inc.
    • 11.2.7. Bracco Imaging
    • 11.2.8. Carestream Health
    • 11.2.9. Esaote SpA
    • 11.2.10. Shimadzu Corporation
    • 11.2.11. Samsung Medison
    • 11.2.12. United Imaging Healthcare
    • 11.2.13. PerkinElmer Inc.
    • 11.2.14. Agfa-Gevaert Group
    • 11.2.15. Konica Minolta Healthcare
    • 11.2.16. Mindray Medical International
    • 11.2.17. Neusoft Medical Systems
    • 11.2.18. ViewRay Inc.
    • 11.2.19. Hyperfine Inc.
    • 11.2.20. Median Technologies

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us